Publisher Correction: Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders

Zhen Xia; Qihan Jin; Zhilin Long; Yexuan He; Fuyi Liu; Chengfang Sun; Jinyang Liao; Chun Wang; Chentong Wang; Jian Zheng; Weixi Zhao; Tianxin Zhang; Jeremy N Rich; Yongdeng Zhang; Longxing Cao; Qi Xie

doi:10.1038/s41551-024-01338-9

Publisher Correction: Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders

Nat Biomed Eng. 2024 Dec;8(12):1744. doi: 10.1038/s41551-024-01338-9.

Authors

Zhen Xia^#^{1

2

3

4

5}, Qihan Jin^#^{1

2

5

6}, Zhilin Long^{1

2

3

4

5}, Yexuan He⁵, Fuyi Liu⁷, Chengfang Sun^{1

8}, Jinyang Liao^{1

2

5

6}, Chun Wang⁷, Chentong Wang^{1

2

5

6}, Jian Zheng⁷, Weixi Zhao^{1

2

3

4

5}, Tianxin Zhang^{1

2

5

6}, Jeremy N Rich⁹, Yongdeng Zhang⁵, Longxing Cao^{10

11

12

13}, Qi Xie^{14

15

16

17

18}

Affiliations

¹ Westlake Disease Modeling Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
² Research Center for Industries of the Future, Westlake University, Hangzhou, China.
³ Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
⁴ Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China.
⁵ School of Life Sciences, Westlake University, Hangzhou, China.
⁶ Artificial Intelligence Drug Design Core Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
⁷ Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
⁸ School of Medicine, Zhejiang University, Hangzhou, China.
⁹ University of Pittsburgh Medical Center Hillman Cancer Center, Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
¹⁰ Westlake Disease Modeling Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. caolongxing@westlake.edu.cn.
¹¹ Research Center for Industries of the Future, Westlake University, Hangzhou, China. caolongxing@westlake.edu.cn.
¹² School of Life Sciences, Westlake University, Hangzhou, China. caolongxing@westlake.edu.cn.
¹³ Artificial Intelligence Drug Design Core Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. caolongxing@westlake.edu.cn.
¹⁴ Westlake Disease Modeling Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. xieqi@westlake.edu.cn.
¹⁵ Research Center for Industries of the Future, Westlake University, Hangzhou, China. xieqi@westlake.edu.cn.
¹⁶ Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China. xieqi@westlake.edu.cn.
¹⁷ Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China. xieqi@westlake.edu.cn.
¹⁸ School of Life Sciences, Westlake University, Hangzhou, China. xieqi@westlake.edu.cn.

^# Contributed equally.

PMID: 39663402
DOI: 10.1038/s41551-024-01338-9

No abstract available

Publication types

Published Erratum